Identifying HL7 and HL7 Products

All materials developed for HL7 should clearly identify HL7 and the HL7 website URL. In addition, HL7 holds a number of registered trademarks which must be identified. 

Name
  • When referring to our organization, the following are acceptable:
    • The full name: Health Level Seven® International
    • The acronyms: HL7 International or HL7
    • IMPORTANT: Do not use “Health Level 7” or any other expression.
  • Whenever writing copy about our organization, please make sure the first mention reads:
    •  “Health Level Seven® (HL7®) International”
  • After the full name has been used, subsequent references may use just the initials: “HL7”
URL

Our preferred format: HL7.org

Trademarks

Whenever using an HL7 graphic that includes a registered trademark symbol, a trademark statement must be placed near the first use of that graphic. For example:

®Health Level Seven, HL7, CDA, FHIR and the FHIR [FLAME DESIGN] are registered trademarks of Health Level Seven International, registered with the United States Patent and Trademark Office. These trademarks are used with the permission of HL7 and the use of these trademarks does not constitute HL7’s approval or endorsement.

Identifying HL7 Product Names
  1. Whenever writing copy about HL7 product names referenced in this guide, please ensure that you first list out the product’s full name for the first mention. For example:
    • HL7 Fast Healthcare Interoperability Resources (HL7 FHIR®)
    • HL7 Clinical Document Architecture (HL7 CDA®)
    • HL7 Version 2 (HL7 V2)
  2. After the full name has been used, subsequent references may use the acronyms:
    • FHIR
    • CDA
    • V2
  3. Whenever these trademarked products are mentioned, the trademark statement at left must accompany it somewhere in the document. For detailed information see “Guide to Using HL7 Trademarks” at https://www.HL7.org/legal/trademarks.cfm